Compositions and methods for treating eye disorders

By using muscarinic agonist and brimonidine composition, combined with nonionic surfactants and adhesives, the side effects problems in presbyopia treatment are solved, and the myopia acuity and focus ability of presbyopia patients are improved for a long time, reducing the ability of presbyopia patients side effects occur.

CN118922190APending Publication Date: 2024-11-08LENZ THERAPEUTICS OPERATIONS INC
0 Cites 0 Cited by

Patent Information

Application Number
CN202280090563.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2021-12-16
Filing Date
2022-12-15
Publication Date
2024-11-08

Smart Images

  • Figure CN118922190A_ABST
    Figure CN118922190A_ABST
Patent Text Reader

Abstract

The present invention is directed to compositions and methods for treating presbyopia, irregular astigmatism, and / or ametropia comprising from about 0.1% to about 4.0% w / v of a muscarinic agonist and from about 0.07% to about 0.15% w / v of brimonidine.
Need to check novelty before this filing date? Find Prior Art